{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:55:41Z","timestamp":1782845741363,"version":"3.54.5"},"reference-count":32,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Infection by human papillomavirus (HPV) induces various cancers, mainly cervical cancer but also anal and pharyngeal cancers. Reunion Island is a French department in the Indian Ocean. Due to the history of its settlement, the island\u2019s population has a wide variety of origins, and the population\u2019s sociodemographic characteristics differ from those of the French mainland. These characteristics make the island\u2019s population an original French population in its own right, particularly in terms of health. Cervical cancer incidence and mortality in Reunion Island are 10.4 per 100,000 and 4.4 per 100,000, respectively, both of which are much higher than those in mainland France. There is also a disparity in the prevalence of different HPV types, with types 33 and 52 being overrepresented and type 18 being underrepresented. However, vaccination and screening coverage in Reunion Island is low. It is important to understand the burden of infection and its risk factors in members of the young Reunionese population at risk of HPV infection to promote and evaluate the implementation of future vaccination and screening programs on a larger scale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The RUN-SurV-HPV study will have the following four objectives: (1) to describe the prevalence of HPV genotypes in a population at risk of sexually transmitted infections in Reunion Island; (2) to describe the prevalence of HPV genotypes by anatomical site, gender, and sexuality; (3) to describe the correlates and risk factors for HPV detection; and (4) to examine HPV genotypes between different anatomical sites.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cross-sectional analyses of 1200 routine vaginal, anal, pharyngeal, and urinary samples collected between October 2020 to December 2022 from female and male patients aged 16 to 30 years undergoing Chlamydia trachomatis testing at a sexually transmitted infection (STI) testing center at Reunion Island will be performed. The population included 333 women who all had vaginal and pharyngeal swabs, with 80 of them also having had an anal swab. There are 167 men who have sex with men who have had anal and pharyngeal swabs, and 120 men who have sex with women who have had a urine swab only. Results will be correlated with sociodemographic and clinical data collected routinely during the consultations. HPV detection and genotyping will be performed using the Anyplex II HPV28 detection assay (Seegene).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The first polymerase chain reactions should begin in November 2023. The first results should be submitted for publication in 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The study will determine HPV prevalence by age, sex, male sexual preference, human immunodeficiency virus status, and STI co-infection. Collecting data from young patients not usually routinely screened for HPV infection will be a simple and reproducible way of better understanding local specificities, encouraging vaccination campaigns in the short-term, and evaluating their effectiveness in the future.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>International Registered Report Identifier (IRRID)<\/jats:title>\n                    <jats:p>DERR1-10.2196\/47379<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/47379","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T02:10:20Z","timestamp":1694139020000},"page":"e47379","source":"Crossref","is-referenced-by-count":0,"title":["Human Papillomavirus (HPV) Infections Among Participants Undergoing Chlamydia trachomatis Testing in Reunion Island (RUN-SurV-HPV Study): Protocol for a Prevalence Study"],"prefix":"10.2196","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8468-3581","authenticated-orcid":false,"given":"Maxence","family":"Gandelin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3283-1450","authenticated-orcid":false,"given":"Phuong Lien","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0109-489X","authenticated-orcid":false,"given":"Emmanuel","family":"Chirpaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5443-1664","authenticated-orcid":false,"given":"Marie-Christine","family":"Jaffar-Bandjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8320-4401","authenticated-orcid":false,"given":"Nicolas","family":"Traversier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4101-8085","authenticated-orcid":false,"given":"Dorothy","family":"Machalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3962-8869","authenticated-orcid":false,"given":"Antoine","family":"Bertolotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"key":"ref1","unstructured":"Comprehensive Cervical Cancer Control: A Guide to Essential Practice - Second EditionWorld Health Organization20142023-10-11https:\/\/www.who.int\/publications\/i\/item\/9789241548953"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.11.796"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s1386-6532(00)00125-6"},{"key":"ref4","unstructured":"Global strategy to accelerate the elimination of cervical cancer as a public health problemWorld Health Organization20202023-10-11https:\/\/www.who.int\/publications\/i\/item\/9789240014107"},{"key":"ref5","unstructured":"BardotMChirpazELes cancers \u00e0 La R\u00e9union. Tableau de bordObservatoire R\u00e9gional de la Sant\u00e9 Oc\u00e9an Indien20192023-10-11ORSOISaint-Denishttps:\/\/www.ors-reunion.fr\/IMG\/pdf\/orsoi_tb_cancers_reunion_2019.pdf"},{"key":"ref6","unstructured":"Le cancer du col de l\u2019ut\u00e9rus \u00e0 La R\u00e9union. Evaluation de la campagne d\u2019incitation au  d\u00e9pistage men\u00e9e par le d\u00e9partement en 2000. Saint-Denis: ORS R\u00e9union; 2002DocPlayer20022023-10-18https:\/\/docplayer.fr\/28213144-Le-cancer-du-col-de-l- uterus-a-la-reunion-evaluation-de-la-campagne-d-incitation-au-depistage-menee-par-le-departement-en-2000.html"},{"key":"ref7","unstructured":"BardotMBernardCBernede-BauduinCDassaBEnqu\u00eate KABP R\u00e9union 2012. Connaissances, attitudes, croyances et comportements des r\u00e9unionnais en mati\u00e8re de risques li\u00e9s aux comportements sexuels. Principaux r\u00e9sultatsObservatoire R\u00e9gional de la Sant\u00e9 La R\u00e9union2023-10-11Saint-DenisORS R\u00e9union\u00a0https:\/\/www.ors-reunion.fr\/IMG\/pdf\/kabp_2012_rapport_final.pdf"},{"key":"ref8","unstructured":"BardotMLa sant\u00e9 des jeunes \u00e0 La R\u00e9union. Tableau de bordObservatoire R\u00e9gional de la Sant\u00e9 Oc\u00e9an Indien20192023-10-11Saint-DenisORSOIhttps:\/\/www.ors-reunion.fr\/IMG\/pdf\/orsoi_tb_sante_jeunes_reunion_2019.pdf"},{"key":"ref9","unstructured":"SanogoA\u00c9tat des lieux du cancer du col de l\u2019ut\u00e9rus \u00e0 La R\u00e9union : les femmes touch\u00e9es r\u00e9unionnaises sont-elles plus jeunes que les femmes m\u00e9tropolitaines? [dissertation]20152023-10-11Universit\u00e9 de Bordeauxhttps:\/\/dumas.ccsd.cnrs.fr\/dumas-01200825"},{"key":"ref10","unstructured":"Recommandation vaccinale. \u00c9largissement de la vaccination contre les papillomavirus aux gar\u00e7onsHaute Autorit\u00e9 de Sant\u00e920192023-10-11https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2019-12\/recommandation_vaccinale_elargissement_de_la_vaccination_contre_les_papillomavirus_aux_garcons.pdf"},{"key":"ref11","unstructured":"Arr\u00eat\u00e9 du 30 novembre 2020 modifiant la liste des sp\u00e9cialit\u00e9s pharmaceutiques remboursables aux assur\u00e9s sociauxL\u00e9gifrance20202023-10-11https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000042607563"},{"key":"ref12","unstructured":"Couverture vaccinale pour papillomavirus (HPV) (%) - sch\u00e9ma complet \u00e0 16 ans en 2021Sant\u00e9 Publique France20222022-10-18https:\/\/geodes.santepubliquefrance.fr\/#c=indicator&f=16&i=cv_hpv.cv_hpv&s=2022&t=a02&view=map2"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.11.081"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2021.102277"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2020.07.001"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33185"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2196\/35695"},{"key":"ref18","unstructured":"Strat\u00e9gie nationale de sant\u00e9 sexuelle. Agenda 2017-2030Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e920172023-10-11Parishttps:\/\/sante.gouv.fr\/IMG\/pdf\/strategie_nationale_sante_sexuelle.pdf"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit192"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70286-8"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1917338"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-14-0687"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.11.019"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-12-1003"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1706-9"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2020-054702"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-43"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2014-051955"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4175-0"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.pvr.2017.10.002"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0267836"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2018.09.012"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2023\/1\/e47379","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:55:09Z","timestamp":1782842109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2023\/1\/e47379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":32,"URL":"https:\/\/doi.org\/10.2196\/47379","relation":{"has-preprint":[{"id-type":"doi","id":"10.2196\/preprints.47379","asserted-by":"object"}]},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]}}}